Antibody Delivery into the Brain by Radiosensitizer Nanoparticles for Targeted Glioblastoma Therapy

BACKGROUND: Glioblastoma is the most lethal primary brain malignancy in adults. Standard of care treatment, consisting of temozolomide (TMZ) and adjuvant radiotherapy (RT), mostly does not prevent local recurrence. The inability of drugs to enter the brain, in particular antibody-based drugs and rad...

Full description

Saved in:
Bibliographic Details
Published in:J Nanotheranostics
Main Authors: Gal, Omer, Betzer, Oshra, Rousso-Noori, Liat, Sadan, Tamar, Motiei, Menachem, Nikitin, Maxim, Friedmann-Morvinski, Dinorah, Popovtzer, Rachela, Popovtzer, Aron
Format: Artigo
Language:Inglês
Published: 2022
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7613745/
https://ncbi.nlm.nih.gov/pubmed/36324626
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jnt3040012
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items